Insights into medication adherence among Jordanian patients with dyslipidemia: evaluating health literacy, well-being, and doctor-patient communication.

Dyslipidemia Jordan doctor patient communication health literacy medication adherence

Journal

Journal of pharmaceutical policy and practice
ISSN: 2052-3211
Titre abrégé: J Pharm Policy Pract
Pays: England
ID NLM: 101627192

Informations de publication

Date de publication:
2024
Historique:
medline: 11 10 2024
pubmed: 11 10 2024
entrez: 11 10 2024
Statut: epublish

Résumé

This study aimed to assess medication adherence among Jordanian patients with dyslipidemia and evaluate the impact of health literacy, well-being, and doctor-patient communication on adherence in this population. Dyslipidemia is a prevalent condition that significantly increases the risk of cardiovascular diseases, and understanding the factors influencing medication adherence is crucial for improving patient outcomes. An observational cross-sectional study was conducted from March to July 2023. A convenience sample of adult Jordanians diagnosed with dyslipidemia was surveyed in a tertiary hospital using validated scales: the Lebanese Medication Adherence Scale-14 (LMAS-14), the Doctor-Patient Communication Scale (DPC), the WHO well-being index, and the health literacy scale. Bivariate analysis and linear regression models were employed to analyze associations. Among 410 participants (mean age 58.62 ± 12.11 years), the mean scores were LMAS-14 (35.10), DPC (55.77), WHO well-being (47.53), and health literacy (38.96). Higher medication adherence was associated with older age ( The findings underscore the substantial interplay of socio-demographic and clinical factors affecting medication adherence. Enhanced public health interventions focusing on improving health literacy, communication quality, and addressing socio-economic conditions are vital for better adherence and patient outcomes in Jordan.

Sections du résumé

Background UNASSIGNED
This study aimed to assess medication adherence among Jordanian patients with dyslipidemia and evaluate the impact of health literacy, well-being, and doctor-patient communication on adherence in this population. Dyslipidemia is a prevalent condition that significantly increases the risk of cardiovascular diseases, and understanding the factors influencing medication adherence is crucial for improving patient outcomes.
Methods UNASSIGNED
An observational cross-sectional study was conducted from March to July 2023. A convenience sample of adult Jordanians diagnosed with dyslipidemia was surveyed in a tertiary hospital using validated scales: the Lebanese Medication Adherence Scale-14 (LMAS-14), the Doctor-Patient Communication Scale (DPC), the WHO well-being index, and the health literacy scale. Bivariate analysis and linear regression models were employed to analyze associations.
Results UNASSIGNED
Among 410 participants (mean age 58.62 ± 12.11 years), the mean scores were LMAS-14 (35.10), DPC (55.77), WHO well-being (47.53), and health literacy (38.96). Higher medication adherence was associated with older age (
Conclusion UNASSIGNED
The findings underscore the substantial interplay of socio-demographic and clinical factors affecting medication adherence. Enhanced public health interventions focusing on improving health literacy, communication quality, and addressing socio-economic conditions are vital for better adherence and patient outcomes in Jordan.

Identifiants

pubmed: 39391822
doi: 10.1080/20523211.2024.2410199
pii: 2410199
pmc: PMC11465368
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2410199

Informations de copyright

© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Déclaration de conflit d'intérêts

No potential conflict of interest was reported by the author(s).

Auteurs

Muna Barakat (M)

Department of Clinical Pharmacy and Therapeutics, School of Pharmacy, Applied Science Private University, Amman, Jordan.

Samar Thiab (S)

Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.

Shaymaa B Abdulrazzaq (SB)

School of Science and Technology, Chemistry Division, University of Camerino, Camerino, Italy.

Marah Al-Jamal (M)

Department of Clinical Pharmacy and Therapeutics, School of Pharmacy, Applied Science Private University, Amman, Jordan.

Fotoh AlHariri (F)

Department of Clinical Pharmacy and Therapeutics, School of Pharmacy, Applied Science Private University, Amman, Jordan.

Rakan Bassam Ammari (R)

Faculty of medicine, Jordan University of Science and Technology, Irbid, Jordan.

Sara Mansour (S)

School of Pharmacy, Lebanese International University, Beirut, Lebanon.

Sami El Khatib (S)

Department of Biomedical Sciences, Lebanese International University, Bekaa, Lebanon.
Center for Applied Mathematics and Bioinformatics (CAMB), Gulf University for Science and Technology, Mubarak Al-Abdullah, Kuwait.

Souheil Hallit (S)

School of Medicine and Medical Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon.
Department of Psychology, College of Humanities, Effat University, Jeddah, Saudi Arabia.

Basile Hosseini (B)

Department of Surgery, Hospices Civils de Lyon, Lyon, France.

Diana Malaeb (D)

College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates.

Hassan Hosseini (H)

Department of Neurology, UPEC-University Paris-Est, Creteil, France.
Department of Neurology, RAMSAY SANTÉ, HPPE, Champigny sur Marne, France.

Classifications MeSH